Of Chemoimmunotherapy Sequences and Delayed Disease-modifying Activity in Advanced Urothelial Carcinoma: Vetus Fit Novum

Eur Urol. 2018 Feb;73(2):153-155. doi: 10.1016/j.eururo.2017.09.012. Epub 2017 Sep 28.

Authors

Andrea Necchi¹, Andrea Anichini², Guru Sonpavde³

Affiliations

¹ Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: [email protected].
² Human Tumors Immunobiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
³ Bladder Cancer Center, Dana Farber Cancer Institute, Boston, MA, USA.

PMID: 28967552
DOI: 10.1016/j.eururo.2017.09.012

No abstract available

Publication types

Editorial
Comment

MeSH terms

Carcinoma, Transitional Cell*
Humans
Immunotherapy
Urinary Bladder Neoplasms
Urologic Neoplasms*